Preclinical studies on [11C]MPDX for mapping adenosine A1 receptors by positron emission tomography
- 63 Downloads
In previousin vivo studies with mice, rats and cats, we have demonstrated that [11C]MPDX ([1-methyl-11C]8-dicyclopropylmethyl-1-methyl-3-propylxanthine) is a potential radioligand for mapping adenosine A1 receptors of the brain by positron emission tomography (PET). In the present study, we performed a preclinical study. The radiation absorbed-dose by [11C]MPDX in humans estimated from the tissue distribution in mice was low enough for clinical use, and the acute toxicity and mutagenicity of MPDX were not found. The monkey brain was clearly visualized by PET with [11C]MPDX. We have concluded that [11C]MPDX is suitable for mapping adenosine A1 receptors in the human brain by PET.
Key wordsadenosine A1 receptor [11C]MPDX central nervous system positron emission tomography
Unable to display preview. Download preview PDF.
- 20.Shimada Y, Nariai T, Ishiwata K, Ishii S, Oda K, Ando M, et al. Decrease in adenosine A1 receptor binding potential after reperfusion as a predictor of severe cerebral ischemic insult—PET multitracer study in cats' model of transient MCA occlusion.J Cereb Blood Flow Metab 1999; 19: S249.Google Scholar
- 24.Ishiwata K, Ido T, Mejia AA, Ichihashi M, Mishima Y. Synthesis and radiation dosimetry of 4-borono-2-[18F]fluoro-D,L-phenylalanine: A target compound for PET and boron neutron capture therapy.Appl Radiat Isot 1991; 142: 325–328.Google Scholar